BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 936.00K | -1.21M | -675.30K | 275.00K | 484.70K |
| Total Depreciation and Amortization | 594.00K | -366.30K | 1.58M | 639.70K | -255.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 657.30K | 3.56M | -- | 940.00K | 1.84M |
| Change in Net Operating Assets | -1.91M | -4.09M | -2.27M | 700.00 | 2.28M |
| Cash from Operations | 272.90K | -2.11M | -1.37M | 1.86M | 4.35M |
| Capital Expenditure | -13.60K | -13.50K | -187.60K | -168.60K | -177.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.60K | -13.50K | -187.60K | -168.60K | -177.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -447.20K | -- | 0.00 | -447.20K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -447.20K | -- | 0.00 | -447.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 259.30K | -2.57M | -1.56M | 1.69M | 3.73M |